Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 468

1.

Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.

Sgambato S, Passariello N, Giugliano D, Torella R, D'Onofrio F.

Acta Diabetol Lat. 1981 Jul-Sep;18(3):235-41.

PMID:
7029989
3.

Glucose metabolism in patients receiving chronic calcitonin treatment.

Guigliano D, Passariello N, Sgambato S, Torella R, Ceriello A, D'Onofrio F.

Diabete Metab. 1982 Sep;8(3):213-6.

PMID:
6754493
4.

Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.

Starke A, Keck E, Berger M, Zimmermann H.

Diabetologia. 1981 May;20(5):547-52.

PMID:
7026328
5.

Abnormalities of endogenous glucagon and insulin in unstable diabetes.

Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS.

Diabetes. 1977 Jan;26(1):36-45.

PMID:
830563
6.

Serum glucagon after arginine infusion in aged and young subjects.

Ferrero E, Casale G, De Nicola P.

J Am Geriatr Soc. 1980 Jun;28(6):285-7.

PMID:
6989881
7.

Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.

Waldhäusl W, Bratusch-Marrain P, Nowotny P.

Endokrinologie. 1979;73(3):323-7.

PMID:
499100
9.

Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.

Brunetti P, Massi-Benedetti M, Puxeddu A, Santeusanio F, Calabrese G, Bolli G, Scionti L, Angeletti G.

Horm Metab Res Suppl. 1979;(8):81-6.

PMID:
395095
10.

Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.

Giugliano D, Passariello N, Torella R, Cerciello T, Varricchio M, Sgambato S.

Acta Diabetol Lat. 1981;18(1):27-36.

PMID:
7211088
11.
12.

Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.

Roti E, Braverman LE, Robuschi G, Salvi M, Gardini E, d'Amato L, Maestri D, Montermini M, Borciani E, Pezzarossa A, et al.

Metabolism. 1986 Apr;35(4):337-42.

PMID:
3515118
13.

Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5.

Ternand C, Go VL, Gerich JE, Haymond MW.

J Pediatr. 1982 Jul;101(1):36-9.

PMID:
7045315
14.
15.

The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.

Hansen AP, Christensen SE, Lundbaek K.

Scand J Clin Lab Invest. 1975 May;35(3):205-10.

PMID:
1153917
16.

Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.

Trovati M, Massara F, Camanni F, Molinatti GM, Lorenzati R, Pagano GF.

J Endocrinol Invest. 1980 Apr-Jun;3(2):189-92.

PMID:
6104680
17.
18.

Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.

Turco G, Brossa C, D'Alberto M, Regis G, Segre G, Bianchi E, Bruni B, Gamba S.

Diabetes. 1981 Aug;30(8):685-93.

PMID:
7018972
19.

Glucagon response to arginine after treatment of diabetes mellitus.

Ohneda A, Ishii S, Horigome K, Yamagata S.

Diabetes. 1975 Sep;24(9):811-9.

PMID:
1158041
20.

Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.

Hermansen K, Schmitz O, Boye N, Christensen CK, Christiansen JS, Alberti KG, Orskov H, Mogensen CE.

Metabolism. 1988 Jul;37(7):640-4.

PMID:
3290622

Supplemental Content

Support Center